慢性基线前列腺炎症与重复活检前列腺癌低分级相关:REDUCE研究结果
该回顾性分析纳入REDUCE研究中889例基线前列腺活检阴性且2年重复活检确诊前列腺癌的50-75岁男性,评估基线急慢性炎症与2年重复活检肿瘤分级的关系。结果显示基线慢性炎症者高分级肿瘤显著更少(多因素OR=0.68,95%CI 0.50-0.93,p=0.016),而急性炎症与分级无关。
要点
- 基线慢性炎症者2年重复活检高分级肿瘤风险显著降低(多因素OR=0.68)。
- 基线急性炎症与肿瘤分级无显著关联(多因素OR=0.78,p=0.34)。
- 慢性炎症与急性炎症显著相关(p<0.001),但与种族、BMI、PSA或DRE无关。
核心结论
- 基线阴性活检中的慢性炎症与随访2年重复活检确诊前列腺癌的低分级相关。
研究设计与样本
- REDUCE研究的回顾性分析,纳入889例50-75岁基线前列腺活检阴性且2年重复活检阳性的男性。
- 急慢性炎症与肿瘤分级由REDUCE研究期间的中心病理确定。
主要发现
- 基线活检中慢性炎症、急性炎症及两者兼有分别检出533例(60%)、12例(1%)和85例(10%)。
- 2年活检时621例(70%)为低分级肿瘤(Gleason评分2-6),268例(30%)为高分级肿瘤(Gleason评分7-10)。
- 基线慢性炎症者高分级肿瘤显著更少(单因素OR 0.64,95%CI 0.47-0.87,p=0.004;多因素OR=0.68,95%CI 0.50-0.93,p=0.016)。
- 基线急性炎症与肿瘤分级无显著关联(单因素OR 0.74,95%CI 0.45-1.20,p=0.22;多因素OR 0.78,95%CI 0.48-1.29,p=0.34)。
临床怎么用
- 对于基线活检阴性但存在慢性前列腺炎症的男性,随访重复活检发现的高分级前列腺癌风险可能较低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We investigated whether baseline acute or chronic prostate inflammation among men with initial negative biopsies for prostate cancer was associated with cancer grade in 2-year repeat biopsies. MATERIALS AND METHODS: Retrospective analyses were conducted of 889 men aged 50 to 75 years old with negative baseline prostate biopsy and 2-year repeat biopsy positive for prostate cancer in the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study. Acute and chronic prostate inflammation and cancer grade were determined by central pathology during the REDUCE study. The association of inflammation in baseline and 2-year repeat biopsy and prostate cancer grade in 2-year repeat biopsy was evaluated with Student's t-test, chi-squared test and multivariable logistic regression. RESULTS: Chronic, acute inflammation and both were detected in 533 (60%), 12 (1%) and 85 (10%) baseline biopsies, respectively. Presence of acute and chronic inflammation were significantly associated with each other (p <0.001). Both types of inflammation were unrelated to race, body mass index, prostate specific antigen or digital rectal exam. At the 2-year biopsy, 621 (70%) tumors were low grade (Gleason scores 2-6) and 268 (30%) were high grade (Gleason scores 7-10). In univariable and multivariable analyses, men with baseline chronic inflammation had significantly fewer high grade tumors (univariable OR 0.64, 95% CI 0.47-0.87, p=0.004; multivariable OR=0.68, 95% CI0.50-0.93, p=0.016) than those without baseline chronic inflammation. Baseline acute inflammation was not associated with tumor grade (univariable OR 0.74, 95% CI 0.45-1.20, p=0.22; multivariable OR 0.78, 95% CI 0.48-1.29, p=0.34). CONCLUSIONS: Chronic inflammation in a negative biopsy was associated with lower prostate cancer grade among men with cancer on follow-up 2-year biopsy.
引用
- Naha U, Nickel JC, Andriole GL, et al. Chronic Baseline Prostate Inflammation is Associated with Lower Tumor Grade in Men with Prostate Cancer on Repeat Biopsy: Results from the REDUCE Study. J Urol. 2020. PMID: 33080149. doi:10.1097/JU.0000000000001407
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。